Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from SciSparc Ltd. ( (SPRC) ) is now available.
SciSparc Ltd. has announced the filing of financial statements related to its merger with AutoMax Motors Ltd., an Israeli vehicle importer and distributor, which was initially agreed upon in April 2024. The merger agreement has undergone several amendments, with the latest on May 8, 2025, deferring the termination right to September 30, 2025. The merger will see AutoMax become a wholly-owned subsidiary of SciSparc, with AutoMax’s shares converted into SciSparc ordinary shares. This strategic move is expected to enhance SciSparc’s market position by diversifying its business operations beyond biotechnology.
More about SciSparc Ltd.
SciSparc Ltd. operates in the biotechnology industry, focusing on the development of therapies for the treatment of central nervous system disorders. The company is based in Tel Aviv, Israel.
Average Trading Volume: 3,900,139
Technical Sentiment Signal: Sell
Current Market Cap: $3.5M
See more insights into SPRC stock on TipRanks’ Stock Analysis page.